Logo image of ALRPD.PA

RAPID NUTRITION PLC (ALRPD.PA) Stock Fundamental Analysis

Europe - EPA:ALRPD - GB00BM9PTW47 - Common Stock

0.0046 EUR
+0 (+4.55%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALRPD. ALRPD was compared to 58 industry peers in the Food Products industry. Both the profitability and financial health of ALRPD have multiple concerns. ALRPD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALRPD had negative earnings in the past year.
ALRPD had negative earnings in 4 of the past 5 years.
In the past 5 years ALRPD always reported negative operating cash flow.
ALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

ALRPD has a worse Return On Assets (-303.92%) than 96.55% of its industry peers.
ALRPD's Return On Equity of -761.48% is on the low side compared to the rest of the industry. ALRPD is outperformed by 94.83% of its industry peers.
Industry RankSector Rank
ROA -303.92%
ROE -761.48%
ROIC N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALRPD.PA Yearly ROA, ROE, ROICALRPD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 52.57%, ALRPD belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
ALRPD's Gross Margin has declined in the last couple of years.
ALRPD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
ALRPD.PA Yearly Profit, Operating, Gross MarginsALRPD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

ALRPD has more shares outstanding than it did 1 year ago.
ALRPD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALRPD has been reduced compared to a year ago.
ALRPD.PA Yearly Shares OutstandingALRPD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALRPD.PA Yearly Total Debt VS Total AssetsALRPD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -52.35, we must say that ALRPD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -52.35, ALRPD is doing worse than 93.10% of the companies in the same industry.
ALRPD has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
ALRPD has a Debt to Equity ratio of 0.21. This is amongst the best in the industry. ALRPD outperforms 84.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -52.35
ROIC/WACCN/A
WACCN/A
ALRPD.PA Yearly LT Debt VS Equity VS FCFALRPD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALRPD has a Current Ratio of 1.77. This is a normal value and indicates that ALRPD is financially healthy and should not expect problems in meeting its short term obligations.
ALRPD has a better Current ratio (1.77) than 68.97% of its industry peers.
ALRPD has a Quick Ratio of 1.10. This is a normal value and indicates that ALRPD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALRPD (1.10) is better than 67.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.1
ALRPD.PA Yearly Current Assets VS Current LiabilitesALRPD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

ALRPD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.71%, which is quite impressive.
Looking at the last year, ALRPD shows a very negative growth in Revenue. The Revenue has decreased by -44.60% in the last year.
Measured over the past years, ALRPD shows a very negative growth in Revenue. The Revenue has been decreasing by -21.65% on average per year.
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.8%
Revenue 1Y (TTM)-44.6%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-36.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 11.70% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALRPD.PA Yearly Revenue VS EstimatesALRPD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ALRPD.PA Yearly EPS VS EstimatesALRPD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 5 10 15 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALRPD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALRPD.PA Price Earnings VS Forward Price EarningsALRPD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALRPD.PA Per share dataALRPD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALRPD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAPID NUTRITION PLC

EPA:ALRPD (9/26/2025, 7:00:00 PM)

0.0046

+0 (+4.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-20 2025-05-20/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.18M
Analysts84.44
Price Target0.51 (10986.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B 10.24
P/tB 10.24
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -303.92%
ROE -761.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.57%
FCFM N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
F-ScoreN/A
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.1
Altman-Z -52.35
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.6%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-36.18%
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A
EBIT growth 1Y74.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.16%
EBIT Next 3Y42.38%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A